Endocyte, Inc. Common Stock
ECYT
ECYT was delisted on the 20th of December, 2018.
102 hedge funds and large institutions have $67.5M invested in Endocyte, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 15 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 29
1% less call options, than puts
Call options by funds: $401K | Put options by funds: $407K
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
2% less funds holding
Funds holding: 104 → 102 (-2)
9% less capital invested
Capital invested by funds: $74.3M → $67.5M (-$6.82M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$1.56M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$1.05M |
| 3 |
D.E. Shaw & Co
New York
|
+$605K |
| 4 |
SIM
Spark Investment Management
New York
|
+$536K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$432K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$491K |
| 2 |
PA
Pinnacle Associates
New York
|
-$450K |
| 3 |
Bank of New York Mellon
New York
|
-$326K |
| 4 |
BAMS
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
|
-$267K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$266K |
ECYT Hedge Fund Activity: Q4 2015 in Review
102 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Endocyte, Inc. Common Stock (ECYT) for Q4 2015, worth a combined $67.5M — down 9.2% from $74.3M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ECYT and 14 opened new positions — a net loss of 1 holder — while 29 trimmed existing stakes and 31 added.
The largest buyer was Baker Bros. Advisors, adding an estimated $1.56M. The largest seller was BlackRock Fund Advisors, cutting an estimated $491K.
- 102 institutional investors held Endocyte, Inc. Common Stock (ECYT) as of Q4 2015, down from 104 in Q3 2015.
- Funds reported $67.5M of Endocyte, Inc. Common Stock stock for Q4 2015, down 9.2% quarter-over-quarter.
- 14 funds opened new Endocyte, Inc. Common Stock positions in Q4 2015 and 15 closed out, a net change of -1 holder.
- The largest Endocyte, Inc. Common Stock buyer in Q4 2015 was Baker Bros. Advisors, an estimated $1.56M added.
- The largest Endocyte, Inc. Common Stock seller in Q4 2015 was BlackRock Fund Advisors, an estimated $491K sold.
Based on aggregated 13F filings for Q4 2015.